Medicare Enrolled
Dr. Rachel Raab, MD
Hematology · Asheville, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Raab from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raab?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Raab
Dr. Rachel Raab is a hematology specialist in Asheville, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Raab performed 43,274 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Raab received a total of $910 from 16 pharmaceutical and/or device companies across 34 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Raab is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 16% volume in NC
$910 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗43,274
Medicare services
Top 16% in NC for hematology
Not available
Unique patients (not deduplicated)
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 7,620 | $18 | $64 |
| Anti-nausea injection (aprepitant) | 7,280 | $1 | $6 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
5,610 | $0 | $4 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
3,420 | $38 | $136 |
| Pembrolizumab injection (Keytruda) | 3,400 | $43 | $157 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,201 | $0 | $1 |
| Injection, fulvestrant, 25 mg | 1,940 | $8 | $139 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,446 | $0 | $1 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
1,400 | $36 | $141 |
| Iron infusion (Monoferric) | 1,100 | $16 | $74 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
940 | $6 | $25 |
| Anti-nausea injection (Aloxi/palonosetron) | 820 | $1 | $41 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
754 | $8 | $29 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
735 | $3 | $135 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
670 | $8 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
468 | $88 | $390 |
| Anti-nausea injection (ondansetron/Zofran) | 440 | $0 | $3 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
292 | $95 | $421 |
| Cyclophosphamide, 100 mg | 275 | $16 | $129 |
| Injection, leucovorin calcium, per 50 mg | 263 | $3 | $14 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
211 | $24 | $135 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
194 | $21 | $103 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
168 | $2 | $7 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 166 | $3 | $42 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
156 | $10 | $67 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
129 | $7 | $126 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
115 | $11 | $66 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
107 | $71 | $210 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
102 | $61 | $277 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
92 | $1 | $4 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
75 | $47 | $205 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
66 | $53 | $234 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
65 | $45 | $208 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
47 | $20 | $164 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 44 | $196 | $1,533 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 43 | $133 | $603 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
38 | $15 | $65 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
37 | $18 | $83 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
36 | $1,082 | $4,447 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
35 | $9 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $135 | $550 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
30 | $1 | $19 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
29 | $2 | $9 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
26 | $38 | $177 |
| New patient office visit, complex (60-74 min) | 24 | $152 | $673 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
21 | $56 | $368 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
20 | $3 | $11 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
17 | $12 | $63 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
17 | $28 | $121 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
17 | $174 | $613 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
15 | $171 | $733 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
15 | $1 | $6 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
12 | $22 | $105 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
20.4% high complexity
73.5% medium
6.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$910
Total received (2018-2024)
Avg $152/year across 6 years
Bottom 36% in NC for hematology
16
Companies
34
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$230
2023
$332
2022
$141
2021
$173
2020
$13
2018
$20
Payments by company (2024)
TerSera Therapeutics LLC
$71
AstraZeneca Pharmaceuticals LP
$43
ABBVIE INC.
$24
Novartis Pharmaceuticals Corporation
$21
Merck Sharp & Dohme LLC
$21
Gilead Sciences, Inc.
$19
Janssen Biotech, Inc.
$16
TAIHO ONCOLOGY, INC.
$15
Top 3 companies account for 59.7% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$176
Novartis Pharmaceuticals Corporation
$152
TerSera Therapeutics LLC
$139
Lilly USA, LLC
$94
Janssen Biotech, Inc.
$68
PFIZER INC.
$55
AstraZeneca Pharmaceuticals LP
$43
Tactile Systems Technology Inc
$38
ABBVIE INC.
$24
Merck Sharp & Dohme LLC
$21
Daiichi Sankyo Inc.
$21
EMD Serono, Inc.
$18
GlaxoSmithKline, LLC.
$17
TAIHO ONCOLOGY, INC.
$15
Genentech USA, Inc.
$14
Amgen Inc.
$13
Top 3 companies account for 51.4% of all-time payments
Associated products mentioned in payments ›
BAVENCIO · CREON · DARZALEX · ELIQUIS · ENHERTU · ERLEADA · Enhertu · Flexitouch Plus · IBRANCE · KISQALI · Kyprolis · LONSURF · LUTATHERA · OJJAARA · PIQRAY · PROMACTA · Perjeta · REBLOZYL · SCEMBLIX · Trodelvy · VERZENIO · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
10
County median income
$70,578
Nearest hospital to ZIP centroid (approximate)
MEMORIAL MISSION HOSPITAL AND ASHEVILLE SURGERY CE
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Raab is a mixed practice specialist, with above-average Medicare volume (top 16% in NC), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Raab experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Raab performed 7,620 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Raab receive payments from pharmaceutical companies?
Yes. Dr. Raab received a total of $910 from 16 companies across 34 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raab's costs compare to other hematologists in Asheville?
Dr. Raab's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raab) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Asheville
Browse hematologists in Asheville ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in NC
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in NC
Which NC hematologists receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
TerSera Therapeutics LLC Payments to Doctors
See all physicians who received payments from TerSera Therapeutics LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology